Oil prices remained under pressure as well
| | |
| | 3/11/2020 | |
This red-hot biotech stock is up a quick double-digits in sheer anticipation of a pending FDA approval announcement. And it's just getting warmed up... and soon could turn $5,000 into $50,000. We've seen this before, with these stocks skyrocketing 117%... 368%... 626%... 1,100% in mere days. Hurry. It happens fast and you don't want to miss a penny in profits. Get the details here. | | |
Dow in Bear Market Territory as COVID-19 Declared Pandemic | By Jake Scott | | It was another bloodbath on Wall Street today. The Dow, S&P 500, and Nasdaq all fell by 4.5% or more, with the blue-chip index closing in bear market territory. The latter two indexes briefly dipped into bear market territory, but ultimately did not close there. The global economy continues to struggle in the face of the spreading coronavirus outbreak, especially after the World Health Organization (WHO) declared COVID-19 "pandemic" status earlier today. Meanwhile, promises of fiscal stimulus measures from the Trump Administration appear vague at best for now. Continue reading for more on today's market, including: - A certain beverage stock fell today despite a major acquisition.
- Shares of Soliton surged after the company received key FDA clearance.
- Plus, Eli Lilly stock soars amid virus threat; an auto stock lost after it closed plants; and one grocer hit record lows.
| >> Continue reading... | |
LATEST HEADLINES |
| Sponsored The key to being consistently profitable as a trader is to focus on high-probability trades. And in this powerful eBook by Dave Acquino, titled The Ultimate Income Trading System, you'll see exactly how Dave and so many of his students do just that. They make 4%, 5% or 6% on each trade and they're in the trade for just 11 hours. CLICK HERE for instant access. | | | | |
To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to: |
| |
No comments:
Post a Comment